Flexion Therapeutics takes its name from the point of value inflection in early pharmaceutical development where the market potential of a drug candidate is first characterized with clinical data: clinical Proof of Concept. In the pharmaceutical industry, achieving this milestone typically takes 3-4 years and $15M to $40M. Flexion's founders, through compact experimental design and maintenance of a lean organization, have consistently delivered Proof of Concept in timeframes of 1 to 2.5 years and costs between $3M and $5M.

Through novel licensing structures, Flexion's unique capabilities are now available to partners in the industry. Flexion provides a new vehicle to define the potential of drug candidates, advance candidates of demonstrated potential through commercialization, and optimize portfolio value.